About ARVN

Arvinas is a biopharmaceutical company dedicated to improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Arvinas uses their proprietary technology platform to engineer proteolysis targeting chimeras, or PROTAC protein degraders, that are designed to harness the body's own natural protein disposal system to selectively and efficiently degrade and remove disease-causing proteins.
Primary Exchange: NASDAQ
SIC Pharmaceutical Preparations
NAICS Pharmaceutical Preparation Manufacturing

ARVN is a Holding In These ETFs:

ETF Ticker ETF Name Net Assets Net Assets Raw # Holdings # Holdings Raw Weight Weight Raw Market Value Market Value Raw
URTY ProShares UltraPro Russell2000 104.2 M 1.04202E+08 2,017 2017 0.0% 1.55584E-05 5 K 5250
UWM ProShares Ultra Russell2000 182.3 M 1.82294E+08 2,017 2017 0.0% 2.33208E-05 9 K 9432
DESC Xtrackers Russell 2000 Comprehensive Factor ETF 10.0 M 1.00072E+07 1,497 1497 0.02% 0.000153921 2 K 1540
VTWG Vanguard Russell 2000 Growth ETF 286.3 M 2.863E+08 1,245 1245 0.01% 0.00012 33 K 33005
VXF Vanguard Extended Market ETF 6.8 B 6.8E+09 3,242 3242 0.0% 3E-05 218 K 218259
ITOT iShares Core S&P Total U.S. Stock Market ETF 18.6 B 1.85536E+10 3,550 3550 0.0% 0 379 K 378805
IWC iShares Microcap ETF 914.4 M 9.14374E+08 1,451 1451 0.04% 0.0004 345 K 344925
IWM iShares Russell 2000 ETF 43.0 B 4.29906E+10 2,006 2006 0.01% 0.0001 2.8 M 2784220
IWN iShares Russell 2000 Value ETF 9.2 B 9.24826E+09 1,370 1370 0.0% 0 208 K 208268
IWO iShares Russell 2000 Growth ETF 9.1 B 9.14116E+09 1,239 1239 0.01% 0.0001 956 K 955850
IWV iShares Russell 3000 ETF 9.8 B 9.77316E+09 2,956 2956 0.0% 0 76 K 76335

Wait, Before You Leave...